Clinical Trials on Maculopathy, Age Related in United Kingdom

Total 24158 results

University of California, Los Angeles
National Eye Institute (NEI); University of Pittsburgh; Jules Stein Eye Institute

Active, not recruiting

GARM II: A Study on the Genetics of Age-related Maculopathy

Age-related Macular Degeneration | Age-related Maculopathy

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Completed

Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)

Maculopathy, Age-Related

United States
US Department of Veterans Affairs

Completed

Measuring Reading Rehabilitation Outcomes

Retinal Degeneration | Age Related Maculopathy

United States
US Department of Veterans Affairs

Completed

A Multi-Center Study of Reading Rehabilitation in Macular Disease

Retinal Degeneration | Age Related Maculopathy

United States
OccuLogix

Suspended

Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis (RHEO-AMD)

Age-Related Maculopathy

United States, Germany, Canada
Genzyme, a Sanofi Company

Completed

Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)

Eye Diseases | Macular Degeneration | Retinal Degeneration | Gene Therapy | Age-Related Maculopathies | Age-Related Maculopathy | Retinal Neovascularization | Maculopathies, Age-Related | Maculopathy, Age-Related | Therapy, Gene

United States
University of Utah
Genentech, Inc.

Terminated

Study Evaluating Genotypes Using Lucentis (SEAGUL)

Age-Related Maculopathy

United States
Alcon Research

Completed

An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD

Macular Degeneration | Maculopathy, Age-Related

United States
Pfizer

Completed

Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration

Eye Diseases | Macular Degeneration | Retinal Degeneration | Age-Related Maculopathies | Age-Related Maculopathy

United States
Pfizer

Terminated

Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration

Age-Related Maculopathy

United States
Oklahoma State University Center for Health Sciences
Novartis

Completed

Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration

Choroidal Neovascularization | Age-Related Maculopathy

United States
Johns Hopkins University

Completed

Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)

Choroidal Neovascularization | Maculopathy, Age-Related

United States
Allergan

Completed

Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)

Choroidal Neovascularization | Age-Related Maculopathy

France, Korea, Republic of, New Zealand, Italy, Israel, United States, Portugal, Australia, United Kingdom
Pfizer

Completed

Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy

Eye Diseases | Macular Degeneration | Retinal Degeneration | Age-Related Maculopathies | Age-Related Maculopathy

United States
Royal Liverpool University Hospital

Unknown

Macular Function During Anti-VEGF Treatment (MAFAT)

Age Related Macular Degeneration

United Kingdom
Second Sight Medical Products

Completed

Argus II Retinal Prosthesis System Dry AMD Feasibility Study Protocol

Age Related Macular Degeneration

United Kingdom
Moorfields Eye Hospital NHS Foundation Trust

Completed

VITAL - Individualising Therapy for Neovascular AMD With Aflibercept (VITAL)

Age Related Macular Degeneration

United Kingdom
OKKO Health

Recruiting

OKKO Health Hyperacuity, Contrast and Colour Game Validation in Age-related Macular Degeneration

Age-Related Macular Degeneration

United Kingdom
OKKO Health
Nottingham University Hospitals NHS Trust; Oxford University Hospitals NHS... and other collaborators

Enrolling by invitation

Patient-centred Smartphone AI for Protecting Vision in Macular Disease

Age-Related Macular Degeneration

United Kingdom
King's College Hospital NHS Trust
King's College London

Completed

A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy. (VITCLEAR)

Age Related Macular Degeneration

United Kingdom
Moorfields Eye Hospital NHS Foundation Trust
University College, London

Recruiting

A Study Of Implantation Of Retinal Pigment Epithelium In Subjects With Acute Wet Age Related Macular Degeneration

Age Related Macular Degeneration

United Kingdom
Moorfields Eye Hospital NHS Foundation Trust

Not yet recruiting

Retinal Pigment Epithelium Safety Study For Patients In B4711001

Age Related Macular Degeneration

United Kingdom
Queen's University, Belfast

Completed

Development of Core Outcomes for Age-related Macular Degeneration (AMD) Interventions- Caregivers' Perspective

Age Related Macular Degeneration

United Kingdom
Moorfields Eye Hospital NHS Foundation Trust
British Eye Research Foundation, operating as Fight for Sight

Completed

EFFECT:Eccentric Fixation From Enhanced Clinical Training (EFFECT)

Age Related Macular Degeneration (ARMD)

United Kingdom
Aston University
The Dunhill Medical Trust

Completed

Colour Contrast Sensitivity for the Early Detection of Wet Age-related Macular Degereration (CEDAR) (CEDAR)

Age Related Macular Degeneration

United Kingdom
Maastricht University Medical Center
Cognis Deutschland GmbH & Co. KG

Completed

The Influence of Lutein Supplements on Age-related Macular Degeneration

Age-Related Macular Degeneration

Netherlands, United Kingdom
Moorfields Eye Hospital NHS Foundation Trust

Completed

Defining Disease Activity in Neovascular AMD With Optical Coherence Tomography Angiography (DANA)

Neovascular Age-related Macular Degeneration

United Kingdom
Lpath, Inc.
Pfizer

Terminated

iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV) (PED)

Pigment Epithelial Detachment

United States
Allergan

Completed

Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)

Choroidal Neovascularization | Age-Related Maculopathy

United States, Australia, Philippines
Allergan

Terminated

Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degeneration

Age-Related Maculopathy | Subfoveal Choroidal Neovascularization

United States
Newtricious R&D BV
Sprim Advanced Life Sciences

Completed

Intervention Trial in Early Age-related Macular Degeneration (I-TEAM)

Age-related Macular Degeneration (AMD)

United States, Germany, Netherlands, United Kingdom
Azienda Ospedaliera Universitaria Mater Domini,...

Recruiting

Photobiomodulation in Dry Age Related Macular Degeneration (DRUSEN)

Age-Related Macular Degeneration

France, Italy, Turkey, United Kingdom
Brighton and Sussex University Hospitals NHS Trust

Completed

Ocular Coherence Tomography During Cataract Assessment

Age Related Macular Degeneration | Cataract Senile | Epiretinal Membrane | Vitreomacular Traction | Macula Hole

United Kingdom
Oraya Therapeutics, Inc.

Withdrawn

Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)

Macular Degeneration | Age-related Macular Degeneration | AMD | Wet AMD | Wet Age-related Macular Degeneration

United Kingdom, Italy
University of Reading

Unknown

Flaxseed Consumption and Bone Metabolism in Postmenopausal Women. (FLAX)

Post Menopausal | Bone Loss, Age Realted

United Kingdom
Bayer
Regeneron Pharmaceuticals

Terminated

A Study to Learn How Well Aflibercept Injected Into the Eye Works and How Safe it is When Given in Customized Treatment Intervals in Patients With an Eye Disease Called Neovascular Age-related Macular Degeneration After Start of Treatment (XPAND)

Neovascular (Wet) Age-related Macular Degeneration

Canada, United Kingdom
Moorfields Eye Hospital NHS Foundation Trust

Completed

Optimising Visual Acuity Measurement in Macular Degeneration (OPTIMISE)

Age Related Macular Degeneration

United Kingdom
Moorfields Eye Hospital NHS Foundation Trust
King's College London; Cardiff University; University College, London; Newcastle... and other collaborators

Recruiting

Quality-Assured Follow-up of Quiescent Neovascular Age -Related maculaR dEgeneration by Non-medical Practitioners (FENETRE)

AMD

United Kingdom
LumiThera, Inc.

Completed

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE II)

Dry Age-related Macular Degeneration

United Kingdom, Spain, France, Germany, Italy
VisionCare, Inc.

Recruiting

Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration

Age-Related Macular Degeneration | AMD

Italy, Ireland, Spain, Germany, United Kingdom
Novartis

Completed

Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular Degeneration

Wet Age-Related Macular Degeneration

United Kingdom, Switzerland
Bayer

Completed

Assessment of Proactive Treatments in Patients With Wet Age-related Macular Degeneration (wAMD) Which Have Never Undergone Treatment of This Particular Disease (XTEND)

Wet Age-related Macular Degeneration

Canada, Spain, Sweden, Belgium, Argentina, Italy, Korea, Republic of, United Kingdom, China, Denmark, France, Norway, Colombia, Australia, Ireland, Switzerland, Thailand
Novartis Pharmaceuticals

Terminated

A Prospective, Observational, Multicentre, 2 Year Study Evaluating the Use of Eylea (Aflibercept) for the Treatment of Neovascular (Wet) Age-related Macular Degeneration in UK NHS Opthalmology Clinics

Wet Age-related Macular Degeneration

United Kingdom
Frank G. Holz
Radboud University Medical Center; Bayer; Hoffmann-La Roche; Novartis Pharmaceuticals and other collaborators

Active, not recruiting

Development of Novel Clinical Endpoints in Intermediate AMD (MACUSTAR)

Age Related Macular Degeneration (AMD)

Germany, Italy, Netherlands, United Kingdom, France, Portugal, Denmark
Novartis Pharmaceuticals

Terminated

Brolucizumab Treatment Experience Study of Patients With nAMD in UK Routine Clinical Practice (BESRA)

Neovascular Age-related Macular Degeneration

United Kingdom
University of Manchester

Completed

Development of a Device to Measure Dark Adaptation

Age-Related Macular Degeneration | Macular Degeneration

United Kingdom
Novartis Pharmaceuticals

Terminated

The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration

Age-related Macular Degeneration | Choroidal Neo-Vascular Age-onset Macular Degeneration

United Kingdom, United States
South Warwickshire NHS Foundation Trust
Aston University

Unknown

Polarization Perception in Health and Disease. Testing a New Sight Test (TaNSiT)

Diabetic Retinopathy | Cataract | Age Related Macular Degeneration | Macular Disease | Pseudophakia | Retinal Disease

United Kingdom
Maculume Ltd.

Completed

Effect of Transcranial NIR Light Upon Memory

Age-related Cognitive Decline

United Kingdom
Pfizer

Terminated

A Study Of Early Markers Of Choroidal Neovascularization

Age-related Macular Degeneration (AMD) | Choroidal Neovascularization (CNV) | Early Markers

Italy, Portugal, United Kingdom

Clinical Trials on Maculopathy, Age Related in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations